Antisoma to present at Canaccord Global Growth Conference
6 August 2010, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC:
ATSMY) announces that senior executive Dr Michael Boss will present at the 30th
Annual Canaccord Global Growth Conference in Boston on Wednesday August 11 at
1pm local time (6pm BST).
A webcast of the presentation will be available on Antisoma's website
athttp://www.antisoma.com/asm/media/webcast/
For live viewing of the webcast, it is recommended that viewers log on 15
minutes early in order to register and download any necessary software.
Enquiries:
Alison Saville
Senior Marketing and Communications Executive
Antisoma plc
+44 (0)20 3249 2100
Background on Antisoma
Antisoma is a London Stock Exchange-listed biopharmaceutical company that
develops novel products for the treatment of cancer. The Company has operations
in the UK and the US. Please visitwww.antisoma.com for further information about
Antisoma.
[HUG#1436343]
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
All reproduction for further distribution is prohibited.
Source: Antisoma plc via Thomson Reuters ONE
